SYMPTOMATIC DERMOGRAPHISM
Clinical trials for SYMPTOMATIC DERMOGRAPHISM explained in plain language.
Never miss a new study
Get alerted when new SYMPTOMATIC DERMOGRAPHISM trials appear
Sign up with your email to follow new studies for SYMPTOMATIC DERMOGRAPHISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug may stop hives from cold and scratching in their tracks
Disease control Recruiting nowThis study tests a new medicine called barzolvolimab for people who get hives from cold temperatures or from scratching their skin. About 240 adults who still have symptoms despite taking allergy pills will receive either the study drug or a placebo. The goal is to see if the dru…
Matched conditions: SYMPTOMATIC DERMOGRAPHISM
Phase: PHASE3 • Sponsor: Celldex Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New injection could calm stubborn hives
Symptom relief Recruiting nowThis early-stage study tests a single dose of a new drug, GTX-B001, for safety. First, healthy volunteers receive the drug to check for side effects. Then, people with chronic inducible urticaria (hives triggered by cold or pressure) receive it to see if it helps. The goal is to …
Matched conditions: SYMPTOMATIC DERMOGRAPHISM
Phase: PHASE1 • Sponsor: Granular Therapeutics Limited • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC